The Dermatological Manifestations of HIV Infection in Ethnic Skin

  • Dina D. Strachan


It is well known that HIV infection is associated with an increased burden of dermatologic disease.1, 2 Some studies show that greater than 90% of HIV-positive people have skin-related complaints.1, 2 Taking into account that the scope of dermatology includes the skin, hair, nails, and mucosa, approximately a quarter of the conditions listed as AIDS-defining illnesses are dermatologic in nature (Table 1).3 Historically, dermatologists were among some of the first doctors to recognize AIDS as a distinct condition.

Dermatologic conditions may be the presenting manifestation of HIV infection, prompting testing, 2 or a marker for disease progression (Table 2).4 Patients may have unusual, more severe, or recalcitrant cases of common conditions (e.g., warts, seborrheic dermatitis) or present with diseases relatively unique to HIV infection (e.g., eosinophilic folliculitis, Kaposi’s sarcoma). In untreated patients, the type of dermatologic disease seen tends to have a pattern that correlates with CD4 count; however, the introduction of HAART in the mid-1990s changed the pattern of the conditions seen.5 Complications from HAART and other medicines used to treat HIV infection, such as lipodystrophy, added to the list of the many HIV-related cutaneous manifestations.


Human Papilloma Virus Herpes Zoster Dark Skin Seborrheic Dermatitis Dermatophyte Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Valle SL. Dermatologic findings related to human immunodeficiency virus infection in high-risk individuals. J Am Acad Dermatol. 1987 Dec; 17(6): 951–61.PubMedCrossRefGoogle Scholar
  2. 2.
    McGrath E, Evans A, Masenga J, Fuller C. Skin diagnoses prompting serological testing for HIV: an 8-year retrospective analysis of HIV testing in a regional dermatology centre, Tanzania. J Am Acad Dermatol. 2005 Mar; 1322.Google Scholar
  3. 3.
    MMWR December 18, 1992/41(RR-17) 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.Google Scholar
  4. 4.
    Wong D and Shumack S. HIV and skin disease. MJA 1996; 164: 352.PubMedGoogle Scholar
  5. 5.
    Zancanaro PCQ, McGirt LY, Mamelak AJ, Nguyen RHN, Martins C. Cutaneous manifestations of HIV in the ear of highly active antiretroviral therapy: An institutional urban clinic experience. J Am Acad Dermatol. 2006; 54: 581–8.PubMedCrossRefGoogle Scholar
  6. 6.
    HIV Infection in the United States Household Population Aged 18–49 Years: Results from 1999–2006. hppt:// (Accessed April 13, 2008)Google Scholar
  7. 7.
    Mirmirani P, Hessol NA, Mauer TA, Berger TG, Nguyen P, Khalsa A, Gurtman A, Micci S, Young M, Holman S, Gange SJ, Greenblatt R. Prevalence and predictors of skin disease in the Women’s Interagency HIV Study (WIHS). J Am Acad Dermatol. 2001; 44: 785–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Barton JC, Buchness MR. Nongenital dermatologic diseases in HIV-infected women. J Am Acad Dermatol. 1999; 40: 938–948.PubMedCrossRefGoogle Scholar
  9. 9.
    Elston D. Community-acquired methicillin-resistant Staphylococcus areus. J Am Acad Dermatol. 2007; 56: 1–16.PubMedCrossRefGoogle Scholar
  10. 10.
    Nguyen MH, Kauffman CA, Goodman RP, Squier C, Arbeit RD, Singh N, Wagener MM, Yu VL. Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients annals of internal medicine. Ann Int Med. 1999 Feb; 130(3): 221–225.PubMedCrossRefGoogle Scholar
  11. 11.
    Miller M, Cespedes C, Vavagiakis P, Klein RS, Lowy FD. Staphylococcus aureus colonization in a community sample of HIV-infected and HIV-uninfected drug users. Staphylococcus aureus colonization in a community sample of HIV-infected and HIV-uninfected drug users. Eur J Clin Microbiol. Infect Dis. 2003 Aug; 22(8): 463–9. Epub 2003 Jul 18.PubMedCrossRefGoogle Scholar
  12. 12.
    Crum-Cianflone NF, Burgi AA, Hale BR. Increasing rates of community-acquired methicillin-resistant Staphylococcus aureus infections among HIV-infected persons. Int J STD AIDS. 2007 Aug; 18(8): 521–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Nelson M, Schiavone M. Emtricitabine (FTC) for the treatment of HIV infection. Int J Clinic Pract. 2004 May; 58(5): 504–10.CrossRefGoogle Scholar
  14. 14.
    Bari MM. Ulcerative syphilis in acquired immunodeficiency syndrome: a case of precocious tertiary syphilis in a patient infected with human immunodeficiency virus. J Am Acad Dermatol. 1989; 21(6): 1310.PubMedCrossRefGoogle Scholar
  15. 15.
    Gutierrez-Galhardho MC, do Valle GF, de Silva FC, Schumbach AO, do Valle ACF. Clinical characteristics and evolution of syphilis in 24 HIV + individuals in Rio de Janeiro, Brazil. Rev Inst Med Trop S Paulo. 2005 May–Jun; 47(3): 153–157.CrossRefGoogle Scholar
  16. 16.
    Cherneskie T. Update and Review of the Diagnosis and Management of Syphilis, Region II STD/HIV Prevention Training Center; New York City Department of Health and Mental Hygiene, New York: 2006.Google Scholar
  17. 17.
    Johnson, RA. Dermatophyte infection in human immune deficiency virus (HIV) disease. J Am Acad Dermatol. 2000 Nov; 43: S135–42.PubMedCrossRefGoogle Scholar
  18. 18.
    Silverberg N, Weinberg J, DeLeo V. Tinea capitis: Focus on African American women. J Am Acad Dermatol. 2002; 46(2): S120–S124.PubMedCrossRefGoogle Scholar
  19. 19.
    Kinloch-de Loës S, de Saussure P, Saurat JH, Stalder H, Hirschel B, Perrin LH. Symptomatic primary infection due to human immunodeficiency virus type 1: review of 31 cases. Clin Infect Dis – 01-JUL-1993; 17(1): 59–65.PubMedCrossRefGoogle Scholar
  20. 20.
    MacNeil RJ, Dinulos JGH. Acute retroviral syndrome. Dermatol Clin. 2006 Oct; 24(4): 431–8.CrossRefGoogle Scholar
  21. 21.
    Smith KJ, Skelton HG, Yeager J, Ledsky R, McCarthy W, Baxter D, et al. Cutaneous findings in HIV-1-positive patients: a 42 month prospective study. Military Medical Consortium for he Advancement of Retroviral Research (MMCARR). J Am Acad Dermatol. Nov 1994; 31(5 pt 1): 746–54.PubMedCrossRefGoogle Scholar
  22. 22.
    Wilkins K, Turner R, Doley J, LeBoit P, Berger T, Maurer T. Cutaneous malignancy and human immunodeficiency virus disease. J Am Acad Dermatol. 2006; 54(2): 189–206.PubMedCrossRefGoogle Scholar
  23. 23.
    Hook EW III, Cannon RO, Nahmias AJ, Lee FF, Campbell CH Jr, glasser D, Quinn TC. Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexual. J Infect Dis. 1992 Feb; 165(2): 251–5.PubMedCrossRefGoogle Scholar
  24. 24.
    Hitti J, Watts DH, Burchett SK, Schacker T, Selke S, Brown ZA, Lawrence C. Herpes simplex virus seropositivity and reactivation at delivery among pregnant women infected with human immunodeficiency virus-1. Am J Obstet Gynecol. 1997 Aug; 177(2): 450–4.PubMedCrossRefGoogle Scholar
  25. 25.
    Reynolds SJ. Developments in STD/HIV Interactions: The Intertwining Epidemics of HIV and HSV-2. Infect Dis Clin North Am. Jun 2005; 19(2): 415–25.PubMedCrossRefGoogle Scholar
  26. 26.
    Wilkinson E. Herpes treatment may limit HIV transmission and progression. Lancet Infect Dis. Apr 2007; 7(4): 249.PubMedGoogle Scholar
  27. 27.
    Xu F, Lee FK, Marrow RA, Sternberg MR, Luther KE, Dubin G, Markowitz LE. Seroprevalence of Herpes Simplex Virus Type 1 in children in the United States. J Pediatr. 2007 Oct; 151(40): 374–7.PubMedCrossRefGoogle Scholar
  28. 28.
    McQuillan GM, Kruszon-Moran D, Kottiri BJ, Curtin LR, Lucas JW, Kington RS. Racial and ethnic differences in the seroprevalence of 6 infectious diseases in the United States: Data from NHANES III, 1988–1994. Am J Public Health. 2004 Nov; 94(11): 1952–1958.PubMedCrossRefGoogle Scholar
  29. 29.
    Nikkels AF, Rentier B, Pierard GE. Chronic varicella-zoster virus skin lesions in patients with human immunodeficiency virus are related to decreased expression of gE and gB. J Infect Dis. 1997 Jul; 176(1): 261–4.PubMedCrossRefGoogle Scholar
  30. 30.
    Schmader K, George LK, Burchett BM, Hamilton JD, Pieper CF. Race and stress in the incidence of herpes zoster in older adults J Am Geriatr Soc.1998 Aug; 46(8): 973–7.PubMedGoogle Scholar
  31. 31.
    Robertson J, Meier M, Wall J, Ying J, Fichtenbaum CJ. Immune reconstitution syndrome in HIV: Validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy. Clin Infect Dis. 2006; 42: 1639–1646.PubMedCrossRefGoogle Scholar
  32. 32.
    Mellanby K. Scabies. 2nd ed. Hampton, Middlesex, UK: E.W. Ltd; 1972: 1–81.Google Scholar
  33. 33.
    Kaplan MH, Sadick NS, Talmor M. Acquired trichomegaly of the eyelashes: a cutaneous marker of acquired immunodeficiency syndrome. J Am Acad Dermatol. 1991 Nov; 25 (5 pt 1): 801–4.PubMedCrossRefGoogle Scholar
  34. 34.
    Almagro M, del Pozo J, Garcia-Silva J, Martinez W, Castro A, Fonseca E. Eyelash length in HIV-infected patients. AIDS. 2003 Jul 25; 17(11): 1695–6.PubMedCrossRefGoogle Scholar
  35. 35.
    Smith KJ, Skelton HG, DeRusso D, Sperling L, Yeager J, Wagner KF, Angritt P. Clinical and histopathologic features of hair loss in patients with HIV-1 infection. J Am Acad Dermatol. 1996 Jan; 34(1): 63–8.PubMedCrossRefGoogle Scholar
  36. 36.
    Tosti A, Gaddoni G, Fanti PA, D’Antuono A, Albertini F. Longitudinal melanonychia induced by 3′-azidodeoxythymidine. Report of 9 cases. Dermatologica. 1990; 180(4): 217–20.PubMedCrossRefGoogle Scholar
  37. 37.
    Dube M, Parker R, Tebas P, Grinspoon S, Zackin R, Robbins G, Roubenoff R, Shafer R, Wininger D, Meyer W, Snyder S, Mulligan K. Glucose metabolism, lipid, and body fat changes in antiretroviral-naïve subjects randomized to nelfinavir or efavirenz plus dual nucleosides. AIDS. 19(16): 1807–1818, November 4, 2005.PubMedCrossRefGoogle Scholar
  38. 38.
    Bugge H, Negaard A, Skeie L, Bergersen B. Hyaluronic acid Treatment of facial fat atrophy in HIV-positive Patients. HIV Med. 2007; 8(8): 475–482.PubMedCrossRefGoogle Scholar
  39. 39.
    Balasubramanyam A. “HIV-associated lipodystrophy syndrome: an accelerated form of the metabolic syndrome of insulin resistance due to altered fat distribution”. Research Initiative/Treatment Action!. Fall 2006. Find 24 May, 2008.Google Scholar
  40. 40.
    Lafeuillade A, Clumeck N, Mallolas J, Jaeger H, Livrozet J-M, Ferreira M, Johnson M, Cheret A, Antoun Z. Comparison of metabolic abnormalities and clinical lipodystrophy 48 weeks after switching from HAART to Trizivir TM versus continued HAART: The Trizal study. HIV Clin Trials. 2003; 4(1): 37–43.PubMedCrossRefGoogle Scholar
  41. 41.
    Fisher AM, Moyle G, Ebrahimi R, and others (SWEET Study Group). Switching from Combivir (CBV, AZT/3TC) to Truvada (TVD, TDF/FTC) Maintains Viral Suppression, Prevents and Reverses Limb Fat Loss, and Improves Biochemical Parameters: Results of a 48 Week Randomised Study. 11th European AIDS Conference (EACS). Madrid, Spain. October 24–27, 2007. Abstract PS5/7.Google Scholar
  42. 42.
    Taylor SC, Callendar VD, Burgess CM. Assessment of Adverse Experiences, keloid formation, and pigmentary changes in subjects with Fitzpatrick skin types IV, V or VI injected with hyaluronic acid gel dermal fillers. Presented November 11, 2007 at the LOreal 4th International Symposium, Ethnic Hair & Skin: Defining the Research Agenda in Miami, Fl.Google Scholar
  43. 43.
    Hirsch H, Kaufmann G, Sendi P, Battegay M. Immune reconstitution in HIV-infected patients. Clini Infect Dis. 2004; 38: 1159–1166.CrossRefGoogle Scholar
  44. 44.
    Taylor SC, Cook-Bolden F, Rahman Z, Strachan D. Acne vulgaris in skin of color. J Am Acad Dermatol. 2002 Feb; 46(2): S98–S106.PubMedCrossRefGoogle Scholar
  45. 45.
    Reynolds SJ, Risbud AR, Shepherd ME, Rompalo AM, Godbole SV, Joshi SN, Diverkar AD, Gangakhedakar RR, Bollinger RC, Mehendale SM. High rates of syphilis among STI patients are contributing to the spread of HIV in India. Sex Transm Infect 2006; 82: 121–126.PubMedCrossRefGoogle Scholar
  46. 46.
    HIV Infection in the United States Household Population Aged 18–49 Years: Results from 1999–2006. Accessed April 13, 2008.

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.New YorkUSA

Personalised recommendations